--- title: 'Director, Clinical Data Management at Entrada Therapeutics' canonical: 'https://feeny.ai/job/director-clinical-data-management-entrada-therapeutics-boston-8qj8p2s34wxj' type: 'job' last_seen: '2026-09-13' --- # Director, Clinical Data Management at Entrada Therapeutics - **Company:** Entrada Therapeutics - **Location:** Boston, MA - **Posted:** 2026-08-11 - **Last confirmed live:** 2026-09-13 - **Apply:** https://job-boards.greenhouse.io/entradatherapeutics/jobs/5209655007 ## Job description The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are a strategic and hands-on leader who is energized by rolling up your sleeves alongside your team, not just directing from a distance. You are willing to step into details whenever needed. You translate strategy into concrete, actionable plans with clear owners, timelines, and milestones. You are a sharp, critical thinker who anticipates issues before they become crises and brings pragmatic, well-reasoned solutions to the table. You care about the science behind the trial, not just the data, and understand how data management decisions affect downstream analysis, medical review, and submission timelines. You follow up and follow through, efficiently connecting problems with solutions. You work successfully in a team environment and have strong interpersonal skills, effectively build working relationships inside and outside of the company. The Opportunity This individual will report to the Head of Biometrics and lead clinical data management across multiple drug development programs, including the development and implementation of data standards. This is a player-coach role: the Director is expected to set DM strategy and data standards, be responsible for the generation of multiple data sets and systems, build upon and lead the existing, high-performing DM function, and partner effectively with our CRO partners to achieve project milestones and clinical study timelines in alignment with company goals and in compliance with local, ICH, GCP, and company policies and procedures. ## Responsibilities - Provide expertise and contribute to the strategy and development of the Clinical Data Management Systems to ensure data quality in support of clinical study data milestones and deliverables - Directly manage, mentor, and develop internal DM staff, and provide day-to-day oversight and leadership of data management personnel at CRO partners, holding both internal staff and vendors accountable to quality and timeline commitments - Lead and support establishment of systems and processes to help ensure clinical data security and integrity. Own end-to-end DM deliverables across the program portfolio. - Develop and oversee the Data Management Plan, database design, edit check specifications, and CRF completion guidelines, ensuring adherence to CDASH, SDTM, and ADaM standards, and quality and consistency across studies. - Stay current on emerging technologies and industry best practices in clinical data management, and proactively evaluate opportunities to apply AI and automation to improve data quality, efficiency, and speed to database lock - Drive standardization and continuous process improvement initiatives through to completion, with defined action plans, milestones, and measurable outcomes - Serve as the primary point of contact for DM matters for the Head of Biometrics and cross-functional leadership internally, and with CRO/vendor partners, auditors, and regulatory agencies externally - Lead CRO/vendor selection, contracting input, ongoing oversight, and performance/budget management for outsourced data management activities - Own inspection and audit readiness for Clinical Data Management, and represent DM directly during regulatory inspections and audits - Proactively identify data quality, timeline, and vendor-performance risks; bring forward clear, actionable mitigation plans rather than open-ended concerns - Represent DM on cross-functional project and submission teams, and communicate DM strategy, status, and risks clearly and concisely to senior leadership The Necessities At Entrada, our passion for science, our devotion to patients and our values drives our behavior: - Humanity - We genuinely care about patients and about one another. - Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients. - Creativity - We are creative problem solvers. - Collaboration - We are more than the sum of our parts. - Curiosity - We have a growth mindset and push conventional thought and theory. To thrive on our team, you will need to come with: - BS in computer science, or a science-based subject (advanced degree a plus), with 10+ years of clinical data management experience in industry, including several years directly managing people and/or CRO data management teams - Strong critical thinking and sound judgment, with a consistent record of turning problems into concrete, actionable plans - Strong CRO vendor management, oversight, and budget management experience - Proficient in Medidata RAVE and other EDC platforms; programming experience is a plus - Experience with CluePoints, Spotfire or similar data review/analytics tools - Experienced in designing clinical trials utilizing CDASH and SDTM standard terminology - Strong understanding of FDA and ICH GCP guidelines to ensure appropriate reporting of clinical trial data - Experience with regulatory GCP inspections/audits preferred - Exceptional written and verbal communication skills, with demonstrated success communicating clearly and credibly with senior leadership, cross-functional partners, CRO/vendor partners, and regulators - Desire to work in a collaborative, fast-paced, and innovative environment - This is a US based remote position, with preference given to local New England based candidates. This role will require minimum monthly or quarterly travel to the Entrada Therapeutics Headquarters located in Boston, MA. What We Offer: Meaningful Work, Fair Rewards, and Real Support At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy, in accordance with certain state requirements in the United States and fostering a fair and open environment at the onset. But we also know it is more than just pay. When you join Entrada, you’ll be part of a mission-driven team with access to comprehensive health, dental and vision coverage; life and disability insurance; with a 401(k) match. We pride ourselves on offering competitive benefits that empower our employees and reflect the value of their contributions – offering paid, gender-inclusive parental leave, holistic support for your health and well-being, education reimbursement, discretionary time off and commuting benefits aligned to your working model. If you find yourself working from our office in Boston’s Seaport District, this puts you steps away from some of the best the city has to offer. At Entrada, our approach to compensation is grounded in transparency, equity, and performance, recognizing the unique contributions each person brings. We believe meaningful work deserves meaningful reward, and view compensation as one way to show appreciation for the collaboration, curiosity, and commitment that drive our mission forward. The salary for this opportunity ranges from $219,000 - $244,500. The final base compensation offered will depend on several considerations which include but may not be limited to a candidate’s skills, competencies, experience and other job-related factors permitted by law. The final salary offered may fall outside of this range. #LI-JF1 #LI-Remote ## Equal Opportunity Employer Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law. Third Party Staffing Agencies Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes. Privacy Statement Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement [here](https://www.entradatx.com/privacy-notice)to understand how and when your data is being used. ## About Entrada Therapeutics ## Company Overview - **One-liner**: Entrada Therapeutics is a clinical-stage biopharmaceutical company developing a proprietary Endosomal Escape Vehicle (EEV™) platform to deliver genetic medicines to previously inaccessible intracellular targets for devastating diseases. - **Entity Type**: Public (NASDAQ: TRDA) - **Headquarters**: Boston, Massachusetts, United States - **Founded**: 2016 - **Founders**: Not publicly listed on the company website; leadership team includes CEO Dipal Doshi, CFO Kory Wentworth, and President of R&D Natarajan Sethuraman. ## Core Business - **Primary industry**: Biotechnology – genetic medicines and intracellular therapeutics - **Target customers**: B2B (partnerships with pharma like Vertex) and ultimately patients with rare neuromuscular and retinal diseases - **Mission**: To treat devastating diseases with intracellular therapeutics, focusing on Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and inherited retinal diseases. ## Products & Services - **EEV™ Platform**: A proprietary, modular delivery technology designed to enable efficient intracellular delivery of oligonucleotides, proteins, and other therapeutics into a wide range of tissues (muscle, retina, etc.) with an improved therapeutic index. - **Clinical-stage programs (DMD franchise)**: - ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51 – exon-skipping oligonucleotides for DMD patients amenable to skipping exons 44, 45, 50, and 51. Multiple programs have advanced into clinical trials in the U.K., EU, and U.S. - **Collaboration program**: - VX-670 (with Vertex Pharmaceuticals) – a clinical-stage therapy for myotonic dystrophy type 1 (DM1). - **Pipeline (preclinical)**: Additional programs in neuromuscular and inherited retinal diseases. ## Market Standing - **Valuation/Market Cap**: $711.3 million (as of mid-2026, per LinkedIn data) - **Key Metric (Revenue)**: $25.4 million annual revenue (2025/2026 estimate from LinkedIn) - **Notable Investors/Partners**: Vertex Pharmaceuticals (strategic collaboration); publicly traded with institutional investors - **Growth Signals**: - IPO in 2021 - 2026 described as a “catalyst-rich period” with multiple clinical data readouts expected - Four clinical-stage DMD programs by year-end 2026 - Positive safety data from ELEVATE-45-201 study leading to dose escalation (10 mg/kg cohort) - Headcount of 168 employees (down ~6% YoY, indicating possible restructuring or natural attrition) ## Competitive Advantages - **Proprietary EEV™ Platform**: Enables intracellular delivery of large molecules that cannot cross cell membranes, unlocking “undruggable” targets – a significant differentiator in the genetic medicine space. - **Modular and versatile**: Platform can be applied across multiple therapeutic areas (neuromuscular, retinal, metabolic) and modalities (oligonucleotides, proteins, gene editors). - **Deep DMD franchise**: Entrada is building one of the broadest exon-skipping pipelines for DMD, targeting multiple patient subpopulations. - **Strategic partnership with Vertex**: Validates the platform and provides co-development resources for DM1. ## Strategic Focus - **Near-term**: Deliver clinical proof-of-concept for DMD programs (data readouts through 2026) and advance VX-670 in DM1. - **Pipeline expansion**: Continue to broaden the EEV platform into new tissues and disease areas, including inherited retinal diseases and metabolic disorders. - **Commercial readiness**: Build internal capabilities for potential future product launches while maintaining a lean, high-impact R&D organization. ## Why Work Here - **Culture**: Described as a “tight-knit team of experts and leaders” with a mission-driven, collaborative, and high-energy environment. Values include humanity, curiosity, and a growth mindset. - **Diversity & Inclusion**: As of October 2025, 58% of employees identify as women, 45% as Asian, Hispanic, Latino, African American, or two or more races; 64% of senior leadership and board are women and minorities. Employee Resource Groups (ERGs) are active. - **Work Model**: Flexible working – role-dependent remote options; employees choose where they work best. Commuter benefits (up to $325/month) for those who come to the Boston Seaport office. - **Benefits**: Comprehensive – fully subsidized lunches/snacks, $500 wellbeing stipend, gender-inclusive parental leave, education reimbursement, mental health and financial coaching, HSA contributions, and milestone celebrations. - **Perks**: In-office fuel (free food/drinks), regular team events, and a strong emphasis on work-life balance. - **Open Roles**: Positions include clinical trial management, regulatory affairs, drug substance development, IT support, and more – posted on Greenhouse. ## Sources 1. [entradatx.com](https://www.entradatx.com/) – Company overview, platform, pipeline, mission 2. [entradatx.com/about](https://www.entradatx.com/about) – Leadership team, company history 3. [entradatx.com/careers](https://www.entradatx.com/careers) – Culture, benefits, diversity stats, open positions 4. [linkedin.com/company/entradatx](https://www.linkedin.com/company/entradatx) – Headcount, revenue, market cap, industry classification 5. [job-boards.greenhouse.io/entradatherapeutics](http://job-boards.greenhouse.io/entradatherapeutics) – Current job listings ## Other roles at Entrada Therapeutics - [Associate Director, Drug Product Development & Manufacturing](https://feeny.ai/job/associate-director-drug-product-development-manufacturing-entrada-therapeutics-p593cry5gk61) — Boston, MA - [Associate Director, Analytical Development & Quality Control](https://feeny.ai/job/associate-director-analytical-development-quality-control-entrada-therapeutics-z1f7fbqpchmp) — Boston, MA - [Director, Regulatory Writing](https://feeny.ai/job/director-regulatory-writing-entrada-therapeutics-boston-ab86t5fmrhhn) — Boston, MA - [Biostatistician Lead Consultant](https://feeny.ai/job/biostatistician-lead-consultant-entrada-therapeutics-boston-xm6k30zmvmd1) — Boston, MA - [Associate Manager, Human Resources](https://feeny.ai/job/associate-manager-human-resources-entrada-therapeutics-boston-cdb994v6z81c) — Boston, MA - [Principal Biostatistician](https://feeny.ai/job/principal-biostatistician-entrada-therapeutics-boston-2t2p3g7s40q5) — Boston, MA - [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-entrada-therapeutics-boston-p2v2qj071nzt) — Boston, MA